Drugs & medicalType II

Bd Anti-Kappa Pe

Manufacturing defect

Read the official notice →
Date
2022-05-03
Country
Canada
Classification
Type II
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2022-05-04
  2. CA
    Drugs & medicalType II

    DuoDerm Sealing defect (2021-08-20)

    Labelling and packaging

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType II

    Nimbus 4 & Nimbus Professional mattresses (2021-04-13)

    Manufacturing defect

    Health CanadaOfficial notice →
  4. 2022-05-03
  5. CA
    Drugs & medicalType II

    Somatom Force

    Software defect

    Health CanadaOfficial notice →
  6. CA
    Drugs & medicalType II

    Syngo.Via

    Software defect

    Health CanadaOfficial notice →
  7. CA
    Drugs & medicalType II

    Ih-Qc 3

    Increased risk or new adverse events

    Health CanadaOfficial notice →
  8. CA
    Drugs & medicalType II

    Intelepacs

    Revised instructions for use

    Health CanadaOfficial notice →
See all drugs & medical recalls →